×
About 1,278 results

ALLMedicine™ Infantile Hemangioma Center

Research & Reviews  429 results

A premonitory mark of segmental infantile hemangioma.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328472
CMAJ : Canadian Medical Association Journal = Journal De ... Hung YT, Chung WH et. al.

Jul 12th, 2022 - A premonitory mark of segmental infantile hemangioma.|2022|Hung YT,Chung WH,Chen CB,|diagnosis,diagnosis,

Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma
https://clinicaltrials.gov/ct2/show/NCT02342275

Jun 16th, 2022 - Currently, propranolol is the preferred treatment for problematic proliferating infantile hemangiomas (IHs). Although propranolol is clearly efficacious, rare side effects, such as hypoglycemia, may be life-threatening. The possibility of proprano...

Spinal kaposiform hemangioendotheliomas: is there a role for endovascular treatment?
https://doi.org/10.1159/000525455
Pediatric Neurosurgery; Demartini Z, Afornali S et. al.

Jun 14th, 2022 - Kaposiform hemangioendotheliomas (KHE) are rare vascular neoplasms composed of groups of capillaries and endothelial cells, forming aneurysms and arteriovenous fistulas. They occur mainly in the extremities during early childhood or infancy, and a...

Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients
https://clinicaltrials.gov/ct2/show/NCT04113187

Jun 14th, 2022 - Hereditary Hemorrhagic Telangiectasia (HHT) is a rare systemic autosomal dominantly inherited disorder of angiogenesis. Its major feature is the occurrence in 90% of patients of spontaneous and recurrent epistaxis responsible for iron deficiency a...

Medical management of vascular anomalies of the head and neck.
https://doi.org/10.1111/jop.13324
Journal of Oral Pathology & Medicine : Official Publicati... Léauté-Labrèze C

Jun 7th, 2022 - Depending on impairment, treatment of vascular anomalies is decided on a case-by-case basis in pluridisciplinary consultations. Interventional treatments, especially surgery and sclerotherapy, are usually partially efficient and management of pati...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  24 results

Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma
https://clinicaltrials.gov/ct2/show/NCT02342275

Jun 16th, 2022 - Currently, propranolol is the preferred treatment for problematic proliferating infantile hemangiomas (IHs). Although propranolol is clearly efficacious, rare side effects, such as hypoglycemia, may be life-threatening. The possibility of proprano...

Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients
https://clinicaltrials.gov/ct2/show/NCT04113187

Jun 14th, 2022 - Hereditary Hemorrhagic Telangiectasia (HHT) is a rare systemic autosomal dominantly inherited disorder of angiogenesis. Its major feature is the occurrence in 90% of patients of spontaneous and recurrent epistaxis responsible for iron deficiency a...

Role of Propranolol as Compared to Bleomycin in Management of Hemangioma
https://clinicaltrials.gov/ct2/show/NCT05327309

Apr 14th, 2022 - Material & Methods Study design: Randomised controlled trial Place of study: This is study was conducted in the department of paediatric surgery, children hospital, Pakistan institute of medical sciences, Islamabad Duration of study: 24 months Num...

Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)
https://clinicaltrials.gov/ct2/show/NCT02913612

Jan 24th, 2022 - Primary: Describe the efficacy of 0.25% and 0.5% topical timolol maleate Gel-forming solution (GFS) as assessed through Infantile Hemangioma (IH) changes in volume. Secondary: Describe the safety of topical timolol maleate GFS for treatment of IH.

Clinical Characteristics of Infantile Hemangioma
https://clinicaltrials.gov/ct2/show/NCT03331744

Jan 4th, 2022 - Infantile hemangioma (IH) is the most common benign tumor of infancy with an estimated prevalence of 4%-5%. IHs may be presented in any part of body including the visceral organs, but are preferentially located on the face, head and neck area. IHs...

see more →

News  55 results

Unique Dermatology Residency Track Focuses on Rural Placement of Graduates
https://www.medscape.com/viewarticle/973788

May 11th, 2022 - BOSTON – As a former active-duty cavalry officer in the U.S. Army who served a 15-month tour in Iraq in 2003, Adam C. Byrd, MD, isn't easily rattled. On any given day, as the only dermatologist in his hometown of Louisville, Miss., which has a pop...

Study Finds Nadolol Noninferior to Propranolol for Infantile Hemangiomas
https://www.medscape.com/viewarticle/963664

Nov 25th, 2021 - Pediatric dermatologists who treat infantile hemangioma (IH) can consider nadolol as a noninferior — and possibly a better — alternative to the standard treatment propranolol, according to a study published in JAMA Pediatrics. "In our experience, ...

Nadolol bests propranolol for infantile hemangioma treatment out to 52 weeks
https://www.mdedge.com/dermatology/article/242778/pediatrics/nadolol-bests-propranolol-infantile-hemangioma-treatment-out
Doug Brunk

Jul 12th, 2021 - Compared with oral propranolol for the treatment of infantile hemangiomas, oral nadolol resulted in faster and greater size involution and color resolution with a similar safety profile out to 52 weeks, results from a prospective analysis of 71 pa.

An infant girl presents with a growing pink-red leg nodule
https://www.mdedge.com/pediatrics/article/240107/dermatology/infant-girl-presents-growing-pink-red-leg-nodule
Lawrence Eichenfield, MD, Michael Haft, BA, MS4

May 13th, 2021 - The history of a brownish to pink patch with color change and rapid growth within the first year combined with the exam findings, are suggestive of a tufted angioma, though the findings presented may be nonspecific. Dr.

see more →

Patient Education  1 results see all →